17α-Ethinyl estradiol-3-sulfate increases survival and hemodynamic functioning in a large animal model of combined traumatic brain injury and hemorrhagic shock: a randomized control trial

MLA

Andrew R. Mayer, et al. “17α-Ethinyl Estradiol-3-Sulfate Increases Survival and Hemodynamic Functioning in a Large Animal Model of Combined Traumatic Brain Injury and Hemorrhagic Shock: A Randomized Control Trial.” Critical Care, vol. 25, no. 1, Dec. 2021, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s13054-021-03844-7.

APA

Andrew R. Mayer, Andrew B. Dodd, Julie G. Rannou-Latella, David D. Stephenson, Rebecca J. Dodd, Josef M. Ling, Carissa J. Mehos, Cidney R. Robertson-Benta, Sharvani Pabbathi Reddy, Rachel E. Kinsler, Meghan S. Vermillion, Andrew P. Gigliotti, Veronik Sicard, Amy L. Lloyd, Erik B. Erhardt, Jessica M. Gill, Chen Lai, Vivian A. Guedes, & Irshad H. Chaudry. (2021). 17α-Ethinyl estradiol-3-sulfate increases survival and hemodynamic functioning in a large animal model of combined traumatic brain injury and hemorrhagic shock: a randomized control trial. Critical Care, 25(1), 1–13. https://doi.org/10.1186/s13054-021-03844-7

Chicago

Andrew R. Mayer, Andrew B. Dodd, Julie G. Rannou-Latella, David D. Stephenson, Rebecca J. Dodd, Josef M. Ling, Carissa J. Mehos, et al. 2021. “17α-Ethinyl Estradiol-3-Sulfate Increases Survival and Hemodynamic Functioning in a Large Animal Model of Combined Traumatic Brain Injury and Hemorrhagic Shock: A Randomized Control Trial.” Critical Care 25 (1): 1–13. doi:10.1186/s13054-021-03844-7.